Europe Oscillating Positive Expiratory Pressure (OPEP) Devices Market

The Europe oscillating positive expiratory pressure (OPEP) devices market is expected to grow from US$ 54.50 million in 2021 to US$ 39.00 million by 2028; it is estimated to grow at a CAGR of 4.9% from 2021 to 2028.

The incidence of chronic obstructive pulmonary disease (COPD) and cystic fibrosis is rising across the region. According to the World Health Organization (WHO), COPD exacerbations are critical events in the history of COPD. Also, the COPD-related disability and mortality propel the demand for Oscillating Positive Expiratory Pressure (OPEP) devices. Asthma is becoming common among people of all ages, genders, and races. As per the 2018 Global Asthma Report published in Auckland, New Zealand, asthma is the 16th largest cause of disability and the 28th greatest source of disease burden, as assessed by disability-adjusted life years. Asthma is common in high-income nations, whereas the majority of asthma-related deaths occur in low- and middle-income countries. Therefore, the rising prevalence of COPD and asthma propels the demand for mucous clearing devices, such as OPEP devices, which bolsters the growth of the oscillating positive expiratory pressure (OPEP) devices market.

With new features and advanced technologies, vendors can attract new customers and expand their footprints in emerging markets.This factor is likely to drive the Europe oscillating positive expiratory pressure (OPEP) devices market at a notable CAGR during the forecast period.

Europe Oscillating Positive Expiratory Pressure (OPEP) Devices Market Revenue and Forecast to 2028 (US$ Million)

 

Get more information on this report Request Free Sample PDF

Europe Oscillating Positive Expiratory Pressure (OPEP) Devices Strategic Insights

Strategic insights for the Europe Oscillating Positive Expiratory Pressure (OPEP) Devices provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

Europe Oscillating Positive Expiratory Pressure (OPEP) Devices Report Scope

Europe Oscillating Positive Expiratory Pressure (OPEP) Devices Regional Insights

The geographic scope of the Europe Oscillating Positive Expiratory Pressure (OPEP) Devices refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

Europe Oscillating Positive Expiratory Pressure (OPEP) Devices Market Segmentation

The Europe oscillating positive expiratory pressure (OPEP) devices market is segmented on the basis of product, indication, distribution channel, and country. Based on product, the market is segmented into mouthpiece PEP devices, face mask PEP devices, and bottle PEP devices. In 2021, the mouthpiece PEP devices segment accounted for the largest market share; and it is likely to register the highest CAGR during the forecast period. Based on indication, the market is categorized into chronic obstructive pulmonary disease (COPD), asthma, bronchitis, bronchiectasis, cystic fibrosis, and others. In 2021, the chronic obstructive pulmonary disease (COPD) segment accounted for the largest share of the market; however, the asthma segment is likely to register the highest CAGR during the forecast period. Based on distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. In 2021, the hospital pharmacies segment held the largest market share; however, the retail pharmacies segment is expected to register the highest CAGR in the market during the forecast period. Further, based on country, the market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. In 2021, Germany held the largest market share, and France is expected to register the highest CAGR during the forecast period.

Allergan Plc.; PARI GmbH; Smiths Medical; AirPhysio; Mercury Medical; CEGLA Medizintechnik GmbH & Co. KG; and Medica Holdings, LLC are among some of the leading companies operating in the Europe oscillating positive expiratory pressure (OPEP) devices market.